scispace - formally typeset
L

Luciano A. Sposato

Researcher at University of Western Ontario

Publications -  187
Citations -  73617

Luciano A. Sposato is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Stroke & Atrial fibrillation. The author has an hindex of 49, co-authored 161 publications receiving 56573 citations. Previous affiliations of Luciano A. Sposato include Spanish National Research Council & Diego Portales University.

Papers
More filters
Journal ArticleDOI

Current practice and attitudes of stroke physicians towards rhythm-control therapy for stroke prevention: results of an international survey

TL;DR: In this article , an online survey was conducted among stroke physicians to assess current practice and attitudes toward rhythm control in patients with atrial fibrillation and acute ischemic stroke between December 22nd 2021 and March 24th 2022.
Journal ArticleDOI

Deep learning prediction of stroke thrombus red blood cell content from multiparametric MRI.

TL;DR: In this article , the authors evaluated the ability of CNNs to predict ischemic stroke thrombus red blood cell (RBC) content using multiparametric MR images, and the network was assessed for its ability to quantitatively predict RBC content and to classify thrombi into RBC-rich and RBCpoor groups.
Journal ArticleDOI

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke

TL;DR: OAC use in patients with AFDAS was associated with reduced risk of ischemic stroke recurrence, without an increased risk of ICH, which supports current guidelines recommending OACs for secondary stroke prevention in patientswith AF, regardless of the time of diagnosis.
Journal ArticleDOI

Abstract 12706: Stroke Risk and Oral Anticoagulation Use With Extended Cardiac Monitoring for Atrial Fibrillation versus Usual Care: A Systematic Review With Meta-Analysis

TL;DR: In this paper , the authors performed a systematic review and meta-analysis of randomized trials evaluating prolonged monitoring versus usual care, with the goal of preventing thromboembolic events.